Foresite Capital Opportunity Management V, LLC Pardes Biosciences, Inc. Call Options Transaction History

Foresite Capital Opportunity Management V, LLC

  • $33.3 Million
  • Q3 2022

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding PRDS

# of Institutions
2
Shares Held
5.23M
Call Options Held
0
Put Options Held
0
View Full List

About PARDES BIOSCIENCES, INC.

PRDS Quotes by TradingView
  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track Foresite Capital Opportunity Management V, LLC Portfolio

Follow Foresite Capital Opportunity Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Opportunity Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Opportunity Management V, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email